3,5-dibromo-1-(cyclohexylmethyl)-1H-1,2,4-triazole, 95.0%, 5g

1H-indene, 95.0%, 5g

D-arginine monohydrochloride, min. 99%, for biochemistry, 1 g, plastic packaging.

7-Bromo-2,4-dichloro-8-fluoroquinazoline, 97%, 25g

TAZEMETOSTAT, 98%, 250mg

4-Phenyl-tetrahydro-pyran-4-carboxylic acid, 95.0%, 2.5g

(1S)-1-(2-Methoxyphenyl)propylamine hydrochloride, 95.0%, 1g

2,6-Dichloropyridine-4-carboxylic acid, 97.0%, 50g

5-Aminothiazolo[4,5-d]pyrimidin-2(3H)-one, 97%, 250mg

2-AMINO-5-BROMO-4-FLUOROBENZONITRILE, 95.0%, 25g

(5-Methyl-3-nitro-pyrazol-1-yl)-acetic acid, 95.0%, 5g

Bis(1,5-cyclooctadiene)nickel(0) (Wax encapsulated) (ca. 0.05mmol/capsule)5each

4-HYDROXY-3-METHOXY-5-METHYLBENZONITRILE, 95.0%, 250mg